# Lecture 10: Hepatobiliary Anatomy and Physiology ## Unit 2.2: Gastrointestinal System --- ## Learning Objectives By the end of this lecture, students will be able to: 1. Describe the gross and microscopic anatomy of the liver 2. Explain hepatic blood flow and the portal system 3. Describe the major metabolic functions of the liver 4. Explain bilirubin metabolism and bile formation 5. Describe gallbladder anatomy and function 6. Explain the anatomy and function of the biliary system --- ## Liver Gross Anatomy The liver occupies the right upper quadrant of the abdomen, situated beneath the diaphragm and protected by the lower rib cage. As the largest solid organ in the body, the liver weighs between 1.2 and 1.5 kilograms in adults. It presents two surfaces: the diaphragmatic surface, which is smooth and convex to conform to the undersurface of the diaphragm, and the visceral surface, which is irregular and bears impressions from adjacent structures including the stomach, duodenum, kidney, and hepatic flexure of the colon. The liver attaches to the diaphragm and anterior abdominal wall via the falciform ligament and coronary ligaments. Anatomic division of the liver recognizes four lobes based on surface landmarks. The right lobe constitutes the largest portion, separated from the smaller left lobe by the falciform ligament on the diaphragmatic surface. The caudate lobe lies posteriorly, receiving blood supply from both right and left hepatic arteries and draining directly into the inferior vena cava. The quadrate lobe sits inferiorly between the gallbladder fossa and the ligamentum teres (the remnant of the umbilical vein). Functional segmental anatomy, described by Couinaud, provides a more surgically relevant organization based on the distributions of the hepatic veins and portal vein branches. The liver divides into eight functionally independent segments, each with its own portal pedicle (containing portal vein, hepatic artery, and bile duct branches) and hepatic venous drainage. The middle hepatic vein defines the plane separating the right liver (segments 5 through 8) from the left liver (segments 1 through 4). This segmental concept enables surgeons to perform anatomic resections (segmentectomy or sectorectomy) while preserving vascular supply and biliary drainage to the remaining liver. The porta hepatis represents the hilum of the liver, a transverse fissure on the visceral surface through which structures enter and exit the organ. The portal vein occupies the posterior position, the hepatic artery lies anterior and to the left, and the bile duct courses anterior and to the right. The mnemonic "portal vein is posterior" helps recall this arrangement. Lymphatic vessels and nerves also traverse the porta hepatis. Panel A: Anterior view of the liver with surface landmarks including the falciform ligament dividing right and left lobes, ligamentum teres, gallbladder position, and diaphragmatic attachment via coronary ligaments. Panel B: Visceral surface view showing the quadrate lobe between the gallbladder and ligamentum teres, caudate lobe posteriorly, porta hepatis as a horizontal fissure, and impressions from the stomach, duodenum, kidney, and hepatic flexure. Panel C: Couinaud segmental anatomy with all eight segments numbered and color-coded, the middle hepatic vein dividing right liver segments 5-8 from left liver segments 1-4, portal pedicles entering each segment, and hepatic veins draining to the IVC. Panel D: Cross-sectional view through the porta hepatis showing the spatial relationship of the portal vein posteriorly, hepatic artery anterior and to the left, and bile duct anterior and to the right, with the mnemonic that the portal vein is posterior. --- ## Hepatic Blood Supply The liver receives approximately twenty-five percent of cardiac output, reflecting its central metabolic role. Uniquely among solid organs, the liver has a dual blood supply. The portal vein delivers seventy-five percent of total hepatic blood flow but only fifty percent of the liver's oxygen supply, as it carries partially deoxygenated blood. The hepatic artery contributes the remaining twenty-five percent of blood flow while providing the other fifty percent of oxygen delivery. The portal vein forms behind the pancreatic neck from the confluence of the splenic vein and superior mesenteric vein. The inferior mesenteric vein typically joins the splenic vein, and gastric veins drain directly into the portal vein. This configuration ensures that nutrient-rich blood from the entire gastrointestinal tract passes through the liver before entering the systemic circulation, enabling first-pass metabolism of absorbed substances. Normal portal venous pressure ranges from five to ten millimeters of mercury. The hepatic artery originates from the celiac trunk, which gives rise to the common hepatic artery. After giving off the gastroduodenal artery, it continues as the proper hepatic artery, which divides into right and left hepatic arteries at the porta hepatis. Anatomic variations are common, occurring in approximately twenty percent of individuals. The most frequent variant involves a replaced right hepatic artery arising from the superior mesenteric artery rather than the celiac trunk, a critical consideration during hepatic surgery and transplantation. Hepatic venous drainage flows through the right, middle, and left hepatic veins, which empty directly into the inferior vena cava just below the diaphragm. The caudate lobe drains through small veins directly into the inferior vena cava, a feature that preserves its function in Budd-Chiari syndrome when the main hepatic veins are occluded. The hepatic arterial buffer response represents an important autoregulatory mechanism. When portal venous flow decreases, hepatic arterial flow increases compensatorily to maintain total hepatic blood flow and oxygen delivery. This mechanism is mediated by adenosine washout: reduced portal flow decreases adenosine clearance, and the accumulated adenosine causes hepatic arterial vasodilation. This buffer response provides critical protection during conditions that compromise portal venous flow. Panel A: Dual blood supply schematic with the portal vein in blue contributing 75% of flow and 50% of oxygen and the hepatic artery in red contributing 25% of flow and 50% of oxygen, with flow arrows proportional to each contribution. Panel B: Portal vein formation showing the splenic vein receiving the inferior mesenteric vein, joining the superior mesenteric vein behind the pancreatic neck to form the portal vein, with gastric vein tributaries indicated, and normal portal venous pressure of 5-10 mmHg. Panel C: Hepatic artery anatomy from the celiac trunk origin through the common and proper hepatic arteries dividing into right and left branches, with a replaced right hepatic artery variant from the superior mesenteric artery shown in dotted lines as the most common variant occurring in 20% of individuals, alongside hepatic venous drainage through right, middle, and left hepatic veins into the IVC with small caudate lobe veins draining directly. Panel D: Hepatic arterial buffer response showing the adenosine-mediated mechanism where decreased portal venous flow reduces adenosine washout, accumulated adenosine causes hepatic arterial vasodilation, and compensatory arterial flow increases to maintain total hepatic blood flow and oxygen delivery. --- ## Liver Microanatomy The liver parenchyma organizes into functional units that can be conceptualized using several models. The classic hepatic lobule model describes a hexagonal unit with the central vein at its center and portal triads at the six corners of the hexagon. Blood flows from the portal triads through hepatic sinusoids toward the central vein, while bile flows in the opposite direction from hepatocytes toward the bile ductules in the portal triad. The portal triad (more accurately a portal tract, as it contains more than three structures) consists of branches of the portal vein, hepatic artery, and bile duct, along with lymphatic vessels. The portal venule delivers nutrient-rich blood from the gastrointestinal tract. The hepatic arteriole provides oxygenated blood and also perfuses the bile duct epithelium. The bile ductule collects bile secreted by hepatocytes and transports it toward larger bile ducts. The hepatic acinus model, described by Rappaport, represents the functional unit of the liver based on blood flow patterns. Each acinus receives blood from a terminal portal venule and hepatic arteriole, with drainage toward two adjacent central veins. This model divides the acinus into three metabolic zones based on proximity to the incoming blood supply. Zone 1 (periportal) surrounds the portal tract, receiving blood with the highest oxygen and nutrient content. Zone 2 (intermediate) occupies the mid-lobular region. Zone 3 (centrilobular) surrounds the central vein and receives blood last, with the lowest oxygen tension. These zones demonstrate distinct metabolic specializations and vulnerabilities. Zone 1 hepatocytes, with abundant oxygen, perform oxidative metabolism including gluconeogenesis, beta-oxidation, cholesterol synthesis, and ureagenesis. Zone 1 also regenerates first after liver injury. Zone 3 hepatocytes specialize in glycolysis, lipogenesis, and drug metabolism through the cytochrome P450 system. Zone 3's low oxygen environment makes it most susceptible to ischemic injury and toxic damage, explaining the centrilobular necrosis pattern seen in acetaminophen toxicity and hypoxic hepatitis. The liver contains several distinct cell types. Hepatocytes constitute approximately sixty percent of liver cells and perform most metabolic functions. Sinusoidal endothelial cells line the hepatic sinusoids and feature fenestrations (small pores) that allow direct contact between plasma and hepatocytes across the space of Disse. Kupffer cells, comprising about fifteen percent of liver cells, are resident macrophages that clear bacteria, endotoxin, and debris from portal blood. Hepatic stellate cells (previously called Ito cells) reside in the space of Disse and store vitamin A; when activated by liver injury, they transform into myofibroblasts that produce collagen, driving hepatic fibrosis. Cholangiocytes line the bile ducts and participate in bile modification. Panel A: Classic hepatic lobule model as a hexagonal structure with the central vein at the center and portal triads at the six corners, hepatic sinusoids radiating from the periphery toward the center carrying blood, and bile canaliculi flowing in the opposite direction toward the portal triads, with portal triad cross-section showing portal venule, hepatic arteriole, and bile ductule. Panel B: Hepatic acinus model with zones 1, 2, and 3 arranged around the terminal afferent vessels, Zone 1 periportal in green receiving the highest oxygen for oxidative metabolism including gluconeogenesis, beta-oxidation, and ureagenesis, Zone 2 intermediate in yellow, and Zone 3 centrilobular in red specializing in glycolysis, lipogenesis, and cytochrome P450 drug metabolism but most vulnerable to ischemic and toxic injury. Panel C: Hepatocyte with characteristic features including abundant mitochondria, rough endoplasmic reticulum, and bile canaliculi, sinusoidal endothelial cell with fenestrations allowing plasma contact with hepatocytes across the space of Disse, and Kupffer cell as a resident macrophage engulfing bacteria and endotoxin from portal blood. Panel D: Hepatic stellate cell in the space of Disse storing vitamin A and shown in its activated myofibroblast form producing collagen to drive hepatic fibrosis, alongside cholangiocytes lining the bile ducts and participating in bile modification. --- ## Hepatic Metabolic Functions The liver serves as the body's central metabolic hub, performing critical functions in carbohydrate, protein, and lipid metabolism. These functions maintain metabolic homeostasis during both fed and fasting states. Carbohydrate metabolism centers on maintaining blood glucose within the normal range of 70 to 100 milligrams per deciliter. In the fed state, insulin promotes hepatic glucose uptake and glycogenesis, the process of converting glucose into glycogen for storage. The liver can store approximately 100 grams of glycogen, sufficient for roughly 24 hours of fasting. During fasting, falling insulin and rising glucagon trigger glycogenolysis, the breakdown of glycogen to release glucose. When glycogen stores deplete, gluconeogenesis synthesizes glucose from non-carbohydrate precursors including lactate, glycerol, and glucogenic amino acids. The liver is the primary site of gluconeogenesis, with the kidneys contributing during prolonged fasting. Protein metabolism in the liver encompasses synthesis, degradation, and nitrogen disposal. The liver synthesizes most plasma proteins, producing 10 to 15 grams of albumin daily. Albumin, with a half-life of approximately 20 days, maintains oncotic pressure and transports various substances. The liver also synthesizes all coagulation factors except factor VIII, acute phase reactants including C-reactive protein and fibrinogen, and binding proteins including transferrin and ceruloplasmin. Amino acid metabolism involves transamination (transferring amino groups) and deamination (removing amino groups). The resulting ammonia undergoes detoxification through the urea cycle, which converts toxic ammonia to urea for renal excretion. Lipid metabolism involves synthesis, modification, and clearance of various lipid species. The liver synthesizes fatty acids from acetyl-CoA when energy is abundant and performs beta-oxidation to generate acetyl-CoA from fatty acids during energy deficit. Cholesterol synthesis and excretion occur primarily in the liver, which converts cholesterol to bile acids for elimination. The liver produces very low-density lipoproteins to export triglycerides to peripheral tissues and synthesizes high-density lipoproteins for reverse cholesterol transport. During prolonged fasting, the liver performs ketogenesis, converting acetyl-CoA to ketone bodies that serve as alternative fuel for the brain and other tissues. Detoxification and biotransformation protect the body from endogenous waste products and exogenous substances including drugs and toxins. Phase I reactions, catalyzed primarily by cytochrome P450 enzymes concentrated in zone 3 hepatocytes, modify substances through oxidation, reduction, or hydrolysis. These reactions typically introduce or expose functional groups for subsequent conjugation. Phase II reactions conjugate the modified substances with polar molecules including glucuronic acid, sulfate, glycine, or glutathione, dramatically increasing water solubility. Phase III involves active transport of the conjugated products into bile or blood for excretion. Panel A: Carbohydrate metabolism with glucose at the center showing glycogenesis and glycogenolysis pathways to and from glycogen storage of approximately 100 grams, gluconeogenesis from lactate, glycerol, and glucogenic amino acids during fasting, and regulatory hormones with insulin promoting storage and glucagon promoting glucose release, maintaining blood glucose at 70-100 mg/dL. Panel B: Protein metabolism showing hepatocyte production of albumin at 10-15 grams daily with a 20-day half-life maintaining oncotic pressure, all coagulation factors except factor VIII, acute phase reactants including CRP and fibrinogen, and the urea cycle converting toxic ammonia to urea for renal excretion. Panel C: Lipid metabolism showing fatty acid synthesis from acetyl-CoA when energy is abundant and beta-oxidation during energy deficit, cholesterol synthesis and conversion to bile acids for elimination, VLDL production for triglyceride export, and ketogenesis during prolonged fasting. Panel D: Drug metabolism through Phase I CYP450 reactions including oxidation, reduction, and hydrolysis concentrated in Zone 3 hepatocytes, Phase II conjugation reactions with glucuronic acid, sulfate, glycine, and glutathione to increase water solubility, and Phase III active transport of conjugated products into bile or blood for excretion. --- ## Bilirubin Metabolism Bilirubin metabolism represents a clinically important hepatic function, as derangements produce jaundice and indicate specific pathophysiological processes. Bilirubin derives primarily from the breakdown of hemoglobin, with approximately eighty percent arising from senescent red blood cell destruction in the spleen and bone marrow. The remaining twenty percent comes from ineffective erythropoiesis and breakdown of other heme-containing proteins including myoglobin and cytochromes. Bilirubin production begins when macrophages phagocytose aged erythrocytes and catabolize hemoglobin. The heme moiety undergoes conversion by heme oxygenase to biliverdin, which is then reduced by biliverdin reductase to bilirubin. This unconjugated (indirect) bilirubin is highly lipophilic and insoluble in water, requiring binding to albumin for transport in plasma. Hepatic processing of bilirubin involves three steps. First, hepatocytes take up bilirubin from albumin via organic anion transporting polypeptides (OATP transporters) on the sinusoidal membrane. Second, within the hepatocyte, uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) conjugates bilirubin with glucuronic acid, producing water-soluble conjugated (direct) bilirubin. Third, the conjugated bilirubin is secreted into bile canaliculi via the multidrug resistance-associated protein 2 (MRP2) transporter. The intestinal fate of bilirubin completes its elimination. Conjugated bilirubin excreted in bile enters the duodenum and passes through the small intestine unchanged. In the colon, bacterial enzymes deconjugate bilirubin and convert it to urobilinogen, a colorless compound. Most urobilinogen is further oxidized to stercobilin, the brown pigment responsible for fecal color. A portion of urobilinogen undergoes enterohepatic circulation, being reabsorbed and returned to the liver for re-excretion. A small fraction escapes hepatic extraction and is excreted by the kidneys as urobilin, contributing to urine color. Hyperbilirubinemia may be predominantly unconjugated or conjugated, indicating different pathophysiological mechanisms. Unconjugated hyperbilirubinemia results from increased bilirubin production (hemolysis), decreased hepatic uptake, or impaired conjugation (Gilbert syndrome, Crigler-Najjar syndrome). Conjugated hyperbilirubinemia indicates impaired canalicular excretion (Dubin-Johnson syndrome, hepatocellular disease) or biliary obstruction. This distinction guides diagnostic evaluation and identifies the level of metabolic dysfunction. Panel A: Bilirubin production with macrophages engulfing senescent red blood cells, heme oxygenase converting heme to biliverdin, biliverdin reductase producing unconjugated bilirubin, and albumin binding for plasma transport, with a sources pie chart showing 80% from red blood cell breakdown and 20% from ineffective erythropoiesis and other heme proteins. Panel B: Hepatic processing in three sequential steps showing OATP-mediated uptake of bilirubin from albumin at the sinusoidal membrane, UGT1A1 conjugation with glucuronic acid in the smooth endoplasmic reticulum producing water-soluble conjugated bilirubin, and MRP2-mediated secretion of conjugated bilirubin into the bile canaliculus. Panel C: Intestinal fate showing conjugated bilirubin in bile entering the duodenum, bacterial conversion to urobilinogen in the colon, oxidation to stercobilin as the brown pigment of feces, enterohepatic circulation with reabsorption to the liver, and urinary excretion of urobilin contributing to urine color. Panel D: Hyperbilirubinemia classification with unconjugated elevation from increased production in hemolysis, decreased uptake, or impaired conjugation in Gilbert and Crigler-Najjar syndromes, versus conjugated elevation from impaired canalicular excretion in Dubin-Johnson syndrome, hepatocellular disease, or biliary obstruction. --- ## Bile Formation and Composition Bile serves essential functions in lipid digestion, fat-soluble vitamin absorption, cholesterol homeostasis, and waste elimination. The liver produces 500 to 1000 milliliters of bile daily, with composition reflecting its multiple roles. Bile composition includes water as the predominant component at approximately ninety-seven percent. Bile acids constitute about 0.7 percent and serve as the key functional components for lipid emulsification. Phospholipids, primarily phosphatidylcholine, comprise about 0.5 percent and enhance the solubilizing capacity of bile acids. Cholesterol accounts for approximately 0.1 percent and is maintained in solution by bile acids and phospholipids. Bilirubin contributes about 0.04 percent. Electrolytes and other solutes complete the composition. Bile acid synthesis occurs exclusively in hepatocytes and represents the major pathway for cholesterol elimination. The rate-limiting enzyme is cholesterol 7α-hydroxylase (CYP7A1), which initiates conversion of cholesterol to bile acids. Primary bile acids synthesized by the liver include cholic acid and chenodeoxycholic acid. Before secretion, these are conjugated with either glycine or taurine to form bile salts, which have enhanced water solubility and remain ionized at intestinal pH. In the colon, bacterial enzymes deconjugate and dehydroxylate primary bile acids to produce secondary bile acids (deoxycholic acid and lithocholic acid). Bile acid synthesis is regulated by negative feedback through the farnesoid X receptor (FXR), which suppresses CYP7A1 when bile acid levels are adequate. Bile flow occurs through two mechanisms. Bile acid-dependent flow accounts for approximately fifty percent of total bile production and results from active secretion of bile acids into the canaliculus, creating an osmotic gradient that draws water. Bile acid-independent flow contributes the remaining fifty percent and is driven by secretion of glutathione and bicarbonate into bile. The functions of bile extend beyond digestion. Bile acids emulsify dietary lipids, breaking large fat droplets into smaller particles that increase surface area for pancreatic lipase action. Bile acids then form mixed micelles with the products of lipid digestion (fatty acids, monoglycerides, cholesterol, fat-soluble vitamins), enabling transport to the intestinal brush border for absorption. Bile provides the major route for cholesterol excretion from the body. Conjugated bilirubin elimination in bile prevents toxic accumulation. Biliary secretion of immunoglobulin A provides antimicrobial protection in the intestinal lumen. Panel A: Bile composition pie chart with water as the dominant component at 97%, expanded to show proportional contributions of bile acids at 0.7%, phospholipids at 0.5%, cholesterol at 0.1%, bilirubin at 0.04%, and electrolytes, with the liver producing 500-1000 mL daily. Panel B: Bile acid synthesis pathway from cholesterol with CYP7A1 as the rate-limiting enzyme, producing primary bile acids cholic acid and chenodeoxycholic acid, conjugated with glycine or taurine to form bile salts, bacterial conversion to secondary bile acids in the colon, and FXR-mediated negative feedback regulation. Panel C: Hepatocyte bile secretion showing canalicular transporters including BSEP for bile salts, MDR3 for phospholipids, and MRP2 for bilirubin, with bile acid-dependent flow creating osmotic gradients accounting for 50% of total bile and bile acid-independent flow from glutathione and bicarbonate secretion contributing the remaining 50%. Panel D: Bile functions including emulsification of dietary fat from large globules into small droplets, mixed micelle formation with bile salts surrounding fatty acids, monoglycerides, cholesterol, and fat-soluble vitamins for transport to the brush border, cholesterol excretion as the major elimination route, and IgA transport providing antimicrobial protection in the intestinal lumen. --- ## Enterohepatic Circulation of Bile Acids The enterohepatic circulation represents a highly efficient recycling system that conserves the bile acid pool while enabling repeated use for lipid digestion. Understanding this circulation explains both normal physiology and pathophysiological consequences of its disruption. The circulation begins with hepatic synthesis and secretion of bile acids into bile. During fasting, bile flows into the gallbladder for storage and concentration. Following a meal, cholecystokinin released from duodenal I cells triggers gallbladder contraction and sphincter of Oddi relaxation, releasing bile into the duodenum. Throughout the jejunum, bile acids participate in lipid digestion and absorption, remaining in the intestinal lumen as they fulfill their emulsification function. Active reabsorption occurs in the terminal ileum through the apical sodium-dependent bile acid transporter (ASBT). This transporter demonstrates remarkable efficiency, reclaiming approximately ninety-five percent of luminal bile acids. The reabsorbed bile acids enter portal blood and return to the liver, where hepatocytes extract them via the sodium-taurocholate cotransporting polypeptide (NTCP) and re-secrete them into bile. The efficiency of this system is remarkable. The total bile acid pool measures only 3 to 4 grams, yet this pool cycles through the enterohepatic circulation six to ten times daily, generating the 20 to 30 grams of bile acids needed for adequate lipid digestion. Only about 0.5 grams escape reabsorption daily and are lost in feces, balanced by hepatic synthesis of new bile acids. Clinical disruption of the enterohepatic circulation produces predictable consequences. Ileal resection or disease (such as Crohn's disease affecting the terminal ileum) impairs bile acid reabsorption. The bile acids reaching the colon cause secretory diarrhea by stimulating colonic water and electrolyte secretion (bile acid diarrhea). Simultaneously, depleted bile acid pools impair fat digestion, causing steatorrhea and fat-soluble vitamin deficiency. Bile acid sequestrants such as cholestyramine intentionally disrupt the enterohepatic circulation; by binding bile acids in the intestine and preventing reabsorption, they force increased hepatic synthesis from cholesterol, lowering serum cholesterol levels. Small intestinal bacterial overgrowth causes premature deconjugation of bile acids in the upper intestine, impairing micelle formation and causing fat malabsorption. Panel A: Complete enterohepatic circulation pathway as an anatomical diagram showing the liver synthesizing and secreting bile acids into bile, gallbladder storage during fasting, CCK-triggered release into the duodenum after a meal, jejunal participation in fat digestion, terminal ileal reabsorption via ASBT, portal venous return, and hepatic extraction via NTCP with continuous cycle arrows. Panel B: Efficiency metrics showing total bile acid pool of 3-4 grams, 6-10 cycles per day, 95% reabsorption efficiency, and only 0.5 grams of daily fecal loss balanced by hepatic synthesis of new bile acids, generating 20-30 grams needed for adequate lipid digestion. Panel C: Clinical disruption from ileal resection or disease showing unabsorbed bile acids reaching the colon and causing secretory diarrhea while simultaneously depleting the bile acid pool and impairing fat digestion to cause steatorrhea and fat-soluble vitamin deficiency. Panel D: Additional disruption scenarios showing bile acid sequestrants such as cholestyramine intentionally binding bile acids to force increased hepatic synthesis from cholesterol and lower serum cholesterol levels, and small intestinal bacterial overgrowth causing premature deconjugation of bile acids in the upper intestine impairing micelle formation and causing fat malabsorption. --- ## Gallbladder Anatomy and Function The gallbladder serves as a reservoir for bile during fasting and delivers concentrated bile to the duodenum when dietary fat triggers cholecystokinin release. This storage and concentration function optimizes bile acid availability for postprandial lipid digestion. The gallbladder lies in the gallbladder fossa on the inferior surface of the liver, between the right and quadrate lobes. It measures 7 to 10 centimeters in length with a capacity of 30 to 50 milliliters. Anatomically, it divides into the fundus (the rounded blind end that may project beyond the liver edge), the body (the main portion), the infundibulum or Hartmann's pouch (a saclike outpouching near the neck where stones commonly lodge), and the neck (which connects to the cystic duct). The cystic artery, typically arising from the right hepatic artery, provides blood supply, running through the hepatocystic triangle (triangle of Calot) bounded by the cystic duct, common hepatic duct, and liver edge. Gallbladder histology differs from other portions of the gastrointestinal tract. The mucosa consists of simple columnar epithelium thrown into folds that flatten as the gallbladder fills. Unlike the intestine, the gallbladder lacks a muscularis mucosae layer. The muscularis consists of interlacing smooth muscle bundles that enable coordinated contraction. The serosa covers the portion facing the peritoneal cavity, while the hepatic surface has adventitia continuous with hepatic connective tissue. Rokitansky-Aschoff sinuses are mucosal herniations through the muscular layer, representing outpouchings that may harbor bacteria or nucleate stone formation. Gallbladder function centers on bile storage and concentration. During fasting, the sphincter of Oddi remains tonically contracted, directing hepatic bile into the gallbladder via the cystic duct. The gallbladder epithelium actively absorbs sodium coupled with water, concentrating bile five to tenfold by reducing its volume while increasing bile acid and other solute concentrations. Following a fat-containing meal, cholecystokinin released from duodenal and jejunal endocrine cells binds receptors on gallbladder smooth muscle, triggering contraction. Simultaneously, CCK relaxes the sphincter of Oddi. The coordinated response delivers concentrated bile to the duodenum precisely when needed for fat digestion. Vagal cholinergic input augments gallbladder contraction. Between meals, cycling of the migrating motor complex periodically contracts the gallbladder to prevent excessive bile stasis. Panel A: Gallbladder position in the gallbladder fossa on the inferior liver surface with anatomical parts labeled including the fundus projecting at the liver edge, body as the main reservoir, infundibulum or Hartmann's pouch where stones commonly lodge, and neck connecting to the cystic duct. Panel B: Triangle of Calot diagram showing boundaries of the cystic duct, common hepatic duct, and liver edge with the cystic artery coursing through typically from the right hepatic artery, and common variant anatomy noted. Panel C: Gallbladder wall histology showing mucosa with simple columnar epithelium thrown into folds, absent muscularis mucosae contrasted with intestinal wall, interlacing smooth muscle bundles, serosa and adventitia, and Rokitansky-Aschoff sinuses as mucosal herniations through the muscular layer. Panel D: Functional diagram showing the fasting state with contracted sphincter of Oddi directing bile to the gallbladder for concentration 5-10 fold through sodium and water absorption, and the fed state with CCK triggering gallbladder contraction and sphincter relaxation to deliver concentrated bile to the duodenum for fat digestion. --- ## Biliary System Anatomy The biliary system conducts bile from hepatocytes to the duodenum through a progressively merging network of channels. Understanding this anatomy is essential for interpreting imaging studies and planning interventional or surgical procedures. Intrahepatic bile ducts begin at the hepatocyte level. Bile canaliculi are small channels formed by specialized regions of adjacent hepatocyte membranes, sealed by tight junctions. Bile secreted into canaliculi flows opposite to sinusoidal blood flow, moving toward the portal tracts. The canals of Hering, or ductules, represent the transition zone where canaliculi merge and become lined by cholangiocytes rather than hepatocytes. These connect to interlobular ducts within the portal triads. Interlobular ducts progressively merge into segmental ducts draining each Couinaud segment, which unite to form the right and left hepatic ducts draining each hemiliver. Extrahepatic bile ducts begin at the confluence of the right and left hepatic ducts, which join to form the common hepatic duct. This confluence typically occurs at the porta hepatis, though anatomic variations are common. The common hepatic duct measures approximately 3 to 4 centimeters in length. The cystic duct, measuring 2 to 4 centimeters and containing spiral valves of Heister that regulate bile flow, joins the common hepatic duct to form the common bile duct. The common bile duct measures 7 to 10 centimeters in total length and is divided into segments. The supraduodenal segment lies above the duodenum in the hepatoduodenal ligament. The retroduodenal segment passes behind the first part of the duodenum. The pancreatic segment courses within or behind the head of the pancreas. The intramural segment traverses the duodenal wall obliquely. Normal common bile duct diameter measures less than 6 millimeters, though this may increase to 10 millimeters following cholecystectomy as the duct assumes a reservoir function. The ampulla of Vater marks the termination of the biliary system, located on the posteromedial wall of the second part of the duodenum. Here, the common bile duct typically joins the main pancreatic duct before opening at the major duodenal papilla. The sphincter of Oddi surrounds this junction and controls bile and pancreatic juice flow. This sphincter has three components: the sphincter choledochus controlling the common bile duct, the sphincter pancreaticus around the pancreatic duct, and the sphincter ampullae surrounding the common channel and papilla. Panel A: Intrahepatic bile duct hierarchy as a progressive magnification series from hepatocyte bile canaliculi formed between adjacent cells with tight junctions, to canals of Hering or ductules with transition to cholangiocyte lining, to interlobular ducts in portal triads, to segmental ducts draining each Couinaud segment, to right and left hepatic ducts, with bile flow direction indicated opposite to sinusoidal blood flow. Panel B: Extrahepatic bile ducts showing the right and left hepatic duct confluence forming the common hepatic duct at 3-4 cm length, the cystic duct junction with spiral valves of Heister, and common bile duct formation with its four segments of supraduodenal, retroduodenal, pancreatic, and intramural at 7-10 cm total length with normal diameter less than 6 mm. Panel C: Ampulla of Vater detailed anatomy showing posteromedial location on the second part of the duodenum, common bile duct and main pancreatic duct junction, and the sphincter of Oddi with three components including the sphincter choledochus around the common bile duct, sphincter pancreaticus around the pancreatic duct, and sphincter ampullae surrounding the common channel and papilla. Panel D: Liver function test interpretation guide showing hepatocellular pattern with elevated ALT and AST suggesting hepatitis or toxins, cholestatic pattern with elevated ALP and GGT suggesting biliary obstruction, mixed pattern with both groups elevated, and the AST to ALT ratio exceeding 2 to 1 suggesting alcoholic liver disease, with synthetic function assessed by albumin and PT/INR. --- ## Liver Function Tests Liver function tests comprise a panel of serum measurements that reflect hepatocyte integrity, biliary function, and synthetic capacity. Proper interpretation requires understanding what each test actually measures and recognizing patterns that point toward specific pathophysiology. Tests of hepatocyte integrity include the aminotransferases. Aspartate aminotransferase (AST) resides in hepatocyte cytoplasm and mitochondria but is also present in cardiac muscle, skeletal muscle, kidney, brain, and red blood cells, limiting its hepatic specificity. Alanine aminotransferase (ALT) is more liver-specific, found predominantly in hepatocyte cytoplasm with lower concentrations in other tissues. Elevation of these enzymes indicates hepatocyte membrane disruption and enzyme leakage rather than synthetic function. The ratio of AST to ALT provides diagnostic clues: a ratio exceeding 2:1 suggests alcoholic liver disease, reflecting alcohol-related mitochondrial injury and pyridoxine deficiency. Mild elevation (less than three times the upper limit of normal), moderate elevation (three to ten times), and marked elevation (greater than ten times) suggest different etiologies and acuity. Tests of biliary function evaluate cholestasis. Alkaline phosphatase (ALP) resides in the canalicular membrane of hepatocytes and in bile duct epithelium, along with bone, intestine, and placenta. Elevation indicates cholestatic injury but requires confirmation of hepatic origin (using GGT or hepatic isoenzyme fractionation) since bone and pregnancy also raise ALP. Gamma-glutamyl transferase (GGT) elevates with cholestasis and is induced by alcohol and certain medications, helping confirm hepatic origin of elevated ALP. Bilirubin fractionation distinguishes conjugated (direct) from unconjugated (indirect) hyperbilirubinemia, localizing dysfunction to the appropriate step in bilirubin metabolism. Tests of synthetic function reflect the liver's capacity to produce proteins. Albumin, with a half-life of approximately 20 days, decreases in chronic liver disease but changes slowly. Prothrombin time and INR, reflecting clotting factor synthesis, respond more rapidly to synthetic dysfunction because factors II, VII, IX, and X have shorter half-lives. Factor VII has the shortest half-life at approximately 6 hours, making PT/INR sensitive to acute liver failure. Factor V, which has the shortest half-life of synthesized factors and is not affected by vitamin K status, may be measured specifically in acute liver failure. Pattern recognition aids interpretation. A hepatocellular pattern features prominently elevated ALT and AST with mild ALP elevation, suggesting hepatitis, toxins, or ischemia. A cholestatic pattern shows prominently elevated ALP and GGT with mild transaminase elevation, indicating biliary obstruction, primary biliary cholangitis, or drug-induced cholestasis. A mixed pattern with both enzyme groups elevated suggests overlapping injury or specific conditions like infiltrative disease. An infiltrative pattern demonstrates elevated ALP with normal bilirubin, characteristic of granulomatous disease or malignant infiltration. Panel A: Three categories of liver function tests showing hepatocyte integrity tests with AST in cytoplasm and mitochondria and ALT more liver-specific in cytoplasm, biliary function tests with ALP on canalicular membranes and in bile duct epithelium, GGT confirming hepatic origin, and bilirubin fractionation, and synthetic function tests with albumin at 20-day half-life, PT/INR reflecting clotting factor synthesis, and factor V with the shortest half-life independent of vitamin K status. Panel B: Pattern recognition matrix with four patterns showing hepatocellular with prominently elevated ALT and AST suggesting hepatitis, toxins, or ischemia, cholestatic with elevated ALP and GGT suggesting biliary obstruction or drug-induced cholestasis, mixed with both groups elevated suggesting overlapping injury, and infiltrative with elevated ALP and normal bilirubin suggesting granulomatous disease or malignant infiltration. Panel C: AST to ALT ratio interpretation showing a ratio exceeding 2 to 1 suggesting alcoholic liver disease from alcohol-related mitochondrial injury and pyridoxine deficiency reducing ALT synthesis. Panel D: Elevation magnitude guide with mild elevation under 3 times the upper limit of normal suggesting chronic disease and fatty liver, moderate elevation of 3-10 times suggesting hepatitis and drug-induced injury, and marked elevation exceeding 10 times suggesting acute viral hepatitis, ischemic hepatitis, and acetaminophen toxicity. --- ## Summary The liver occupies the right upper quadrant as the largest solid organ, organized functionally into eight Couinaud segments based on vascular supply and biliary drainage. A dual blood supply delivers seventy-five percent of flow through the portal vein (nutrient-rich) and twenty-five percent through the hepatic artery (oxygen-rich), with each contributing equally to oxygen delivery. The hepatic arterial buffer response compensates for reduced portal flow through adenosine-mediated arterial vasodilation. Liver microanatomy features the hepatic acinus as the functional unit, with zone 1 (periportal) performing oxidative metabolism and regenerating first, while zone 3 (centrilobular) specializes in drug metabolism but is most vulnerable to ischemia and toxins. Hepatocytes constitute sixty percent of liver cells, with sinusoidal endothelium, Kupffer cells, and stellate cells serving specialized functions. Metabolic functions maintain homeostasis through glycogen storage and gluconeogenesis (carbohydrates), albumin and clotting factor synthesis (proteins), and lipoprotein metabolism with cholesterol regulation (lipids). Drug metabolism proceeds through phase I (CYP450 modification) and phase II (conjugation) reactions. Bilirubin metabolism converts heme-derived unconjugated bilirubin to conjugated form through hepatic UGT1A1, with excretion in bile and bacterial conversion to urobilinogen in the colon. The enterohepatic circulation reclaims ninety-five percent of bile acids in the terminal ileum, cycling the 3 to 4 gram pool six to ten times daily. The gallbladder stores and concentrates bile five to tenfold, releasing it through CCK-mediated contraction when dietary fat reaches the duodenum. The biliary system progresses from canaliculi through intrahepatic ducts to the common bile duct, terminating at the sphincter of Oddi and ampulla of Vater. Liver function tests demonstrate hepatocellular patterns (elevated ALT/AST), cholestatic patterns (elevated ALP/GGT), or mixed patterns, guiding diagnostic evaluation of hepatobiliary disease. --- ## Key Terms | Term | Definition | |------|------------| | Portal vein | Vessel carrying nutrient-rich, partially deoxygenated blood from the gastrointestinal tract to the liver | | Couinaud segments | Eight functionally independent liver segments based on vascular and biliary anatomy | | Kupffer cells | Hepatic resident macrophages lining sinusoids that clear bacteria and debris from portal blood | | Stellate cells | Vitamin A-storing cells in the space of Disse that produce collagen and drive fibrosis when activated | | Bilirubin | Yellow pigment derived from heme breakdown, conjugated in liver and excreted in bile | | Enterohepatic circulation | Recycling pathway returning bile acids from terminal ileum to liver via portal blood | | Sphincter of Oddi | Muscular valve controlling bile and pancreatic juice flow into the duodenum | | Cholestasis | Impaired bile formation or flow, producing elevated alkaline phosphatase and conjugated bilirubin | --- *This content is subject to the [MIT License](https://opensource.org/licenses/MIT). © 2024–2026 Hibbert School of Medicine.*